Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status
<p>Abstract</p> <p>Background</p> <p>Oncoprotein HCCR-1 functions as a negative regulator of the p53 and contributes breast tumorigenesis. The serum HCCR-1 assay is useful in diagnosing breast cancer and mice transgenic for HCCR developed breast cancers. But it is unkno...
Main Authors: | Lee Yu, Jung Sang, Kim Hae, Namkoong Hong, Kim Sanghee, Kim Hyun, Shin Seung, Lee Youn, Ha Seon-Ah, Chung Yeun, Kim Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/51 |
Similar Items
-
Transdifferentiation-inducing <it>HCCR-1 </it>oncogene
by: Kim Jin, et al.
Published: (2010-06-01) -
HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01) -
Lapatinib for HER2 overexpressing breast cancer
by: Jones, Jeremy, et al.
Published: (2009) -
HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis
by: Hur Soo, et al.
Published: (2007-11-01) -
Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
by: Ho Hyun Ryu, et al.
Published: (2021-05-01)